UBS Group
BIOA

UBS Group’s BioAge Labs, Inc. Common Stock BIOA Stock Holding History

UBS Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$94.6K Buy
22,912
+5,109
+29% +$21.1K ﹤0.01% 6019
2025
Q1 		$66.9K Sell
17,803
-86,088
-83% -$324K ﹤0.01% 6078
2024
Q4 		$602K Buy
+103,891
New +$602K ﹤0.01% 4576